Genmab | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Almirall EUR 1.49B 10.37M 2024-06
Amarin USD 531.38M 20.5M 2024-09
Amgen USD 5.88B 1.65B 2024-12
argenx SE 4.26B 3.84B 2024-09
AstraZeneca USD 40.87B 66M 2024-12
Bayer EUR 32.04B 1.49B 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Demant DKK 9.56B 42M 2024-12
Exelixis USD 2.24B 31.22M 2025-01
Fresenius Medical Care EUR 14.58B 214.44M 2024-12
Galapagos EUR 2.9B 34.37M 2024-12
Genmab DKK 36.7B 4.78B 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
GN Store Nord DKK 10.82B 637M 2024-12
GRIFOLS EUR 5.88B 533.83M 2024-12
Hikma Pharmaceutical USD 2.29B 88M 2024-06
Insmed USD 285.38M 198.04M 2024-12
Lonza CHF 9.33B 23M 2024-12
Merck EUR 29.99B 1.66B 2024-12
Novartis USD 44.05B 605M 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 73B 1.36B 2024-06
UCB EUR 10.03B 1.08B 2024-12



Genmab Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.